SPPM Interviews Dr. Gregory Hammer Regarding Olicerdine, a Newly FDA Approved Opioid

Gregory Hammer, MD Professor of Anesthesia & Pediatrics Stanford University School of Medicine   Your browser does not support the video tag. Click here to download video Dr. Genevieve D’Souza, an active member of the communications committee of SPPM, recently interviewed Dr. Gregory Hammer about this new development in pain management. Dr. Greg Hammer is […]

SPPM President Advocates for Safe Pain Management in Pediatric Patients

SPPM is proud to advocate for issues related to pain management in children. Recently, our president, Dr. Rita Agarwal has been featured on two prominent websites discussing current issues around pain management. The first article was featured on Doximity and discusses the utilization of ketamine for non-medical use as a chemical restraint that lead to […]

IASP Data Blitz Submissions

The International Association for the Study of Pain (IASP) invites members and others to submit data blitz submissions to be considered for presentation during the IASP Virtual Series on Pain & Expo. Data blitz live presentations will occur on January 28, 2021 and March 24, 2021. All submissions must be submitted by November 18, 2020 at […]

New SPPM Special Interest Groups

The SPPM Board of Directors is delighted to announce the creation of two NEW Special Interest Groups (SIGs). Creating, Maintaining, and Supporting Pediatric Pain Services SIG There is little information on how to create a new pediatric pain service in institutions that do not have them, or how to maintain and/or optimize existing pain management […]

SPPM/SPA Response to FDA Regarding the Use of Codeine

In 2013 the FDA recommended against the use of codeine in pain medication, or as an antitussive in children less than 12 years of age. In 2015 and 2017 it strengthened its warnings; leading to a contraindication and label changes on codeine containing medications. Click here to view the recommendation. At that time, they added […]